Page last updated: 2024-08-16

temozolomide and apatinib

temozolomide has been researched along with apatinib in 7 studies

Research

Authors	Studies
Feng, M; Gan, W; Huang, Y; Li, X; Liu, J; Shao, Y; Wang, X; Yao, H; Zhang, C; Zhou, Y	1
Sun, X; Xu, X; Xu, Y; Zhan, W; Zhao, L; Zhu, Y	1
Bai, X; Chi, Z; Cui, C; Guo, J; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, B; Wang, X; Yan, X; Yang, Y; Zhou, L	1
Li, J; Shen, Z; Shi, L; Zhang, N; Zhao, S	1
Kan, ANC; Ku, DTL; Lam, YL; Liu, APY; To, KF; Yan, CLS; Yu, SH	1
Cheng, P; Han, Q; Ma, H; Yang, H; Zhao, M; Zhao, Y	1
Bai, X; Cheng, F; Chi, Z; Cui, C; Dai, J; Duan, R; Guo, J; Kong, Y; Li, C; Li, J; Li, S; Lian, B; Mao, L; Pang, Z; Sheng, X; Si, L; Tang, B; Wang, X; Wei, X; Wu, X; Xia, F; Xu, H; Yan, X; Yang, Y; Zhang, C; Zhou, L	1

1 review(s) available for temozolomide and apatinib

Article	Year
Combining apatinib and temozolomide for brainstem glioblastoma: a case report and review of literature. Annals of palliative medicine, 2022, Volume: 11, Issue:1 Topics: Adult; Brain Neoplasms; Brain Stem; Dacarbazine; Glioblastoma; Humans; Male; Pyridines; Temozolomide	2022

2 trial(s) available for temozolomide and apatinib

Article	Year
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy. Melanoma research, 2022, 06-01, Volume: 32, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Immunotherapy; Melanoma; Pyridines; Skin Neoplasms; Temozolomide	2022
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial. JAMA oncology, 2023, 08-01, Volume: 9, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Temozolomide; Vascular Endothelial Growth Factor A	2023

4 other study(ies) available for temozolomide and apatinib

Article	Year
Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2021, Volume: 90 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pyridines; Quality of Life; Survival Rate; Temozolomide; Treatment Outcome	2021
Apatinib and temozolomide in children with recurrent ependymoma: A case report. Medicine, 2022, Sep-16, Volume: 101, Issue:37 Topics: Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Humans; Male; Protein Kinase Inhibitors; Pyridines; Temozolomide	2022
Durable disease control with apatinib, irinotecan and temozolomide in a case of metastatic primitive myxoid mesenchymal tumour of infancy. Pediatric blood & cancer, 2023, Volume: 70, Issue:3 Topics: Humans; Infant; Irinotecan; Neoplasms; Pyridines; Temozolomide	2023
Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report. Medicine, 2022, Dec-09, Volume: 101, Issue:49 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide	2022